Tenaya Therapeutics (TNYA) Assets Average (2021 - 2026)

Tenaya Therapeutics has reported Assets Average for 6 years, with the latest figure at $141.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 6.86% year-over-year to $141.0 million; the trailing twelve-month figure through Mar 2026 stood at $141.0 million (up 6.86% YoY), and the FY2025 full-year result was $133.4 million, down 8.12% from the prior year.
• Assets Average for Q1 2026 stood at $141.0 million, up from $126.0 million in the prior quarter.
• The five-year high for Assets Average was $297.8 million in Q1 2022, with the low at $113.6 million in Q3 2025.
• Average Assets Average over 5 years is $189.6 million, with a median of $177.7 million recorded in 2024.
• Year-over-year, Assets Average slumped 32.21% in 2024 and increased 6.86% in 2026.
• Tracing TNYA's Assets Average over 5 years: stood at $252.6 million in 2022, then dropped by 27.97% to $182.0 million in 2023, then decreased by 28.41% to $130.3 million in 2024, then fell by 3.31% to $126.0 million in 2025, then increased by 11.95% to $141.0 million in 2026.
• The last three Assets Average figures came in at $141.0 million (Q1 2026), $126.0 million (Q4 2025), and $113.6 million (Q3 2025), per Business Quant data.

Peer Comparison